Regulatory Network in Protein Phosphorylation
[Home] [About] [Browse Kinome] [Phosphorylation Prediction] [Expression Analysis] [Statistics] [Help] Version 1.0

[Back to Kinase CDK2]
Substrate: RPA2

Description: Replication protein A 32 kDa subunit (RP-A) (RF-A) (Replicationfactor-A protein 2) (p32) (p34).

Synonyms: REPA2, RPA32, RPA34

Ensembl ID: ENSG00000117748

UniprotKB/SwissProt: RFA2_HUMAN (P15927)

Function: Required for DNA recombination, repair and replication. The activity of RP-A is mediated by single-stranded DNA binding and protein interactions.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus. Note=Also present in PML nuclear bodies. Redistributes to discrete nuclear foci upon DNA damage.
PDB:1DPU
Protein Domain and Phosphorylation Sites:

The phosphorylated sites of RPA2

No.SubstrateUniProtKB IDPositionPhosphoPeptideSolvent AccessibilityCatalytic kinaseSourceComputational Annotation of Catalytic KinaseInteracting PartnersExpression Analysis
1RPA2RFA2_HUMANS4--MWN S GFESY 29.37%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
2RPA2RFA2_HUMANS4--MWN S GFESY 29.37% Phospho.ELM 7.0View   
3RPA2RFA2_HUMANS8NSGFE S YGSSS 32.31%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
4RPA2RFA2_HUMANS8NSGFE S YGSSS 32.31% Phospho.ELM 7.0View   
5RPA2RFA2_HUMANS11FESYG S SSYGG 14.10%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
6RPA2RFA2_HUMANS11FESYG S SSYGG 14.10% Phospho.ELM 7.0View   
7RPA2RFA2_HUMANS12ESYGS S SYGGA 24.18% Phospho.ELM 7.0View   
8RPA2RFA2_HUMANS12ESYGS S SYGGA 24.18%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
9RPA2RFA2_HUMANS13SYGSS S YGGAG 29.51% Phospho.ELM 7.0View   
10RPA2RFA2_HUMANS13SYGSS S YGGAG 29.51%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
11RPA2RFA2_HUMANT21GAGGY T QSPGG 26.33%DNAPK Phospho.ELM 7.0  ViewAnalyzing
12RPA2RFA2_HUMANT21GAGGY T QSPGG 26.33%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
13RPA2RFA2_HUMANT21GAGGY T QSPGG 26.33%ATM Phospho.ELM 7.0  ViewAnalyzing
14RPA2RFA2_HUMANT21GAGGY T QSPGG 26.33%DNAPK Swiss-Prot 55.0 (in vitro)  ViewAnalyzing
15RPA2RFA2_HUMANS23GGYTQ S PGGFG 20.08%CDC2(CDK1) Phospho.ELM 7.0 ViewAnalyzing
16RPA2RFA2_HUMANS23GGYTQ S PGGFG 20.08%CDC2 HPRD:01566(in vitro)  ViewAnalyzing
17RPA2RFA2_HUMANS29PGGFG S PAPSQ 18.67%CDC2 Swiss-Prot 55.0 (in vitro)  ViewAnalyzing
18RPA2RFA2_HUMANS29PGGFG S PAPSQ 18.67%CDC2 HPRD:01566(in vitro)  ViewAnalyzing
19RPA2RFA2_HUMANS29PGGFG S PAPSQ 18.67%CDC2(CDK1) Phospho.ELM 7.0 ViewAnalyzing
20RPA2RFA2_HUMANS33GSPAP S QAEKK 44.09%DNAPK HPRD:01566(in vitro)  ViewAnalyzing
21RPA2RFA2_HUMANS33GSPAP S QAEKK 44.09%DNAPK Swiss-Prot 55.0 (in vitro)  ViewAnalyzing
22RPA2RFA2_HUMANS33GSPAP S QAEKK 44.09%DNAPK Phospho.ELM 7.0  ViewAnalyzing